OncoResponse Revenue and Competitors
Estimated Revenue & Valuation
- OncoResponse's estimated annual revenue is currently $3.4M per year.
- OncoResponse's estimated revenue per employee is $81,600
Employee Data
- OncoResponse has 42 Employees.
OncoResponse's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
OncoResponse Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24.3M | 189 | -6% | N/A | N/A |
#2 | $0.2M | 4 | 33% | N/A | N/A |
#3 | $5M | 50 | 0% | N/A | N/A |
#4 | $2.1M | 27 | 0% | N/A | N/A |
#5 | $0.1M | 2 | 0% | N/A | N/A |
#6 | $5.1M | 48 | -8% | N/A | N/A |
#7 | $923.3M | 6455 | 8% | N/A | N/A |
#8 | $5.5M | 54 | -4% | N/A | N/A |
#9 | $3.8M | 97 | 21% | N/A | N/A |
#10 | $11.3M | 111 | 12% | N/A | N/A |
What Is OncoResponse?
OncoResponse leverages the power of the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer. Through our partnership with MD Anderson Cancer Center, we deploy a unique and transformative approach to the discovery of cancer therapeutics. OncoResponse is based in Seattle, Washington.
keywords:N/A
N/A
Total Funding
42
Number of Employees
$3.4M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
OncoResponse News
2022-03-22 - OncoResponse Announces Oral Presentation at Festival of ...
OncoResponse is a clinical-stage, immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $35M | 42 | -25% | N/A |
#2 | $4.5M | 42 | 8% | $2.2M |
#3 | $15.7M | 42 | -14% | N/A |
#4 | $16.3M | 42 | -16% | N/A |
#5 | $8.8M | 42 | 2% | N/A |